Chickasaw Capital Management LLC Gilead Sciences, Inc. Transaction History

Chickasaw Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 11, 2019	SELL	$60.54 - $79.0 $1.37 Million - $1.79 Million	-22,600 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $32,439 - $37,840	500 Added 2.26%	22,600 $1.6 Million
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $1.59 Million - $1.89 Million	22,100	22,100 $1.79 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Chickasaw Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Chickasaw Capital Management LLC with notifications on news.